Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Antagonism of peptidoleukotrienes and inhibition of systemic anaphylaxis by RG 12525 in guinea pigs

Journal Article · · Life Sci.; (United States)

RG 12525 was determined to be a specific, competitive and orally effective antagonist of the peptidoleukotrienes, LTC/sub 4/, LTD/sub 4/ and LTE/sub 4/, in several assays utilizing guinea pigs. In vitro, RG 12525 competitively inhibited /sup 3/H-LTD/sub 4/ binding to lung membranes and competitively antagonized the spasmogenic activity of LTC/sub 4/, LTD/sub 4/ and LTE/sub 4/ on lung strips with > 8000 fold selectivity. In vivo, RG 12525 orally inhibited LTD/sub 4/ induced wheal formation LTD/sub 4/ induced bronchoconstriction and anaphylactic death and antigen induced bronchoconstriction. RG 12525 represents a significant improvement in receptor affinity and oral efficacy and thus, is a valuable pharmacological tool to evaluate peptidoleukotrienes in allergic diseases.

Research Organization:
Rorer Central Research, Horsham, PA (USA)
OSTI ID:
6149918
Journal Information:
Life Sci.; (United States), Journal Name: Life Sci.; (United States) Vol. 44:13; ISSN LIFSA
Country of Publication:
United States
Language:
English